Carmen Unzu

773 total citations
24 papers, 475 citations indexed

About

Carmen Unzu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Carmen Unzu has authored 24 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Oncology. Recurrent topics in Carmen Unzu's work include Virus-based gene therapy research (10 papers), CRISPR and Genetic Engineering (9 papers) and CAR-T cell therapy research (6 papers). Carmen Unzu is often cited by papers focused on Virus-based gene therapy research (10 papers), CRISPR and Genetic Engineering (9 papers) and CAR-T cell therapy research (6 papers). Carmen Unzu collaborates with scholars based in Spain, United States and Switzerland. Carmen Unzu's co-authors include Ana Sampedro, Antonio Fontanellas, Gloria González‐Aseguinolaza, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Itsaso Mauleón, Nerea Zabaleta, Ignacio Melero, Nicholas D. Weber and Julio Sanmiguel and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Carmen Unzu

20 papers receiving 469 citations

Peers

Countries citing papers authored by Carmen Unzu

Since Specialization

Citations

This map shows the geographic impact of Carmen Unzu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Unzu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Unzu more than expected).

Fields of papers citing papers by Carmen Unzu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Unzu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Unzu. The network helps show where Carmen Unzu may publish in the future.

Co-authorship network of co-authors of Carmen Unzu

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Unzu. A scholar is included among the top collaborators of Carmen Unzu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Unzu. Carmen Unzu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Operationalising a Haemophilia Gene Editing Lexicon for Practical Use 2025 ·Haemophilia ·(unknown), Cédric Hermans, Carmen Unzu, Mark A. Kay, Flora Peyvandi, Paul Smith, Wolfgang Miesbach, Glenn F. Pierce, Kate Khair, Leonard A. Valentino, Steven W. Pipe, (unknown), (unknown), (unknown), (unknown), David E. Gutstein, Craig M. Kessler	0
2	Clinical perspective: Advancing hemophilia treatment through gene therapy approaches 2025 ·Molecular Therapy ·Courtney D. Thornburg, S. W. PIPE, Alessio Cantore, Carmen Unzu, (unknown), Wolfgang Miesbach	0
3	A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results 2024 ·Haemophilia ·Cédric Hermans, Leonard A. Valentino, Courtney D. Thornburg, Carmen Unzu, Mark A. Kay, Flora Peyvandi, Paul Smith, Wolfgang Miesbach, (unknown), Glenn F. Pierce, Kate Khair, Steven W. Pipe, (unknown), (unknown), (unknown), (unknown), (unknown), Craig M. Kessler	2
4	Harnessing gene therapy for liver metabolic dysfunction: An innovative approach to MASH treatment 2024 ·Molecular Therapy ·Carmen Unzu, Maite G. Fernández‐Barrena	0
5	Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations 2024 ·Molecular Therapy — Nucleic Acids ·Matthieu Drouyer, (unknown), (unknown), Adrian Westhaus, Suzanne Scott, Scott Lee, Peter G.R. Burke, Simon McMullan, José L. Lanciego, (unknown), (unknown), Carmen Unzu, Gloria González‐Aseguinolaza, (unknown), Leszek Lisowski	4
6	Gene therapy for liver diseases — progress and challenges 2023 ·Nature Reviews Gastroenterology & Hepatology ·Nerea Zabaleta, Carmen Unzu, Nicholas D. Weber, Gloria González‐Aseguinolaza	39
7	Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), África Vales, Gloria González‐Aseguinolaza, Carmen Unzu, Urtzi Garaigorta	0
8	Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate 2022 ·Nature Communications ·Eva Andrés‐Mateos, Lukas D. Landegger, Carmen Unzu, Jean M. Phillips, Brian M. Lin, Nicholas A. Dewyer, Julio Sanmiguel, Fotini Nicolaou, Michelle D. Valero, (unknown), William F. Sewell, (unknown), Michael J. McKenna, Konstantina M. Stanković, Luk H. Vandenberghe	35
9	High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Fotini Nicolaou, Simon Pacouret, Eric Zinn, Julio Sanmiguel, Eva Andrés‐Mateos, Carmen Unzu, Amy J. Wagers, Luk H. Vandenberghe	50
10	Ancestral library identifies conserved reprogrammable liver motif on AAV capsid 2022 ·Cell Reports Medicine ·Eric Zinn, Carmen Unzu, (unknown), Heikki Turunen, Nerea Zabaleta, Julio Sanmiguel, (unknown), (unknown), Cheikh Tacko Diop, Erin Merkel, (unknown), (unknown), (unknown), Kathleen A. Messemer, Jennifer F. De Los Santos, (unknown), Eva Andrés‐Mateos, Amy J. Wagers, Christopher Tipper, Luk H. Vandenberghe	16
11	Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2018 ·Hepatology ·Carmen Unzu, Evarist Planet, Nathalie Brandenberg, Floriane Fusil, Marco Cassano, Jimena Pérez‐Vargas, Marc Friedli, François–Loïc Cosset, Matthias P. Lütolf, Barbara E. Wildhaber, Didier Trono	23
12	Human Hepatocyte‐Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues 2016 ·Stem Cells International ·Carmen Unzu, Marc Friedli, Alexis Bosman, Marisa Jaconi, Barbara E. Wildhaber, Anne‐Laure Rougemont	1
13	Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression 2015 ·Gene Therapy ·Carmen Unzu, Ignacio Melero, Sandra Hervás‐Stubbs, Ana Sampedro, Uxua Mancheño, Aizea Morales‐Kastresana, (unknown), Rafael Enrı́quez de Salamanca, Alberto Benito, Antonio Fontanellas	13
14	Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency 2014 ·Genome Research ·Marc Friedli, Priscilla Turelli, Adamandia Kapopoulou, Benjamin Rauwel, (unknown), Helen M. Rowe, Gabriela Ecco, Carmen Unzu, Evarist Planet, Angelo Lombardo, Bastien Mangeat, Barbara E. Wildhaber, Luigi Naldini, Didier Trono	77
15	Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus 2014 ·PLoS ONE ·Carmen Unzu, Ignacio Melero, Aizea Morales‐Kastresana, Ana Sampedro, (unknown), Arantza Azpilikueta, María C. Ochoa, Juan Dubrot, Eduardo Martínez‐Ansó, Antonio Fontanellas	7
16	Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice 2013 ·Human Molecular Genetics ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Manuela González-Aparicio, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Tomás Aragón, Antonio Fontanellas	18
17	Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates 2012 ·Journal of Translational Medicine ·Carmen Unzu, Sandra Hervás‐Stubbs, Ana Sampedro, Itsaso Mauleón, Uxua Mancheño, Carlos Alfaro, Rafael Enrı́quez de Salamanca, Alberto Benito, Stuart G. Beattie, Harald Petry, Jesús Prìeto, Ignacio Melero, Antonio Fontanellas	56
18	Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates 2010 ·Molecular Therapy ·Antonio Fontanellas, Sandra Hervás‐Stubbs, Itsaso Mauleón, Juan Dubrot, Uxua Mancheño, María Collantes, Ana Sampedro, Carmen Unzu, Carlos Alfaro, Asís Palazón, Cristian Smerdou, Alberto Benito, Jesús Prìeto, Iván Peñuelas, Ignacio Melero	24
19	Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice 2010 ·Molecular Therapy ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Manuel Alegre, Stuart G. Beattie, Rafael Enrı́quez de Salamanca, Jolanda Snapper, Jaap Twisk, Harald Petry, Gloria González‐Aseguinolaza, Julio Artieda, Maria Sol Rodríguez-Peña, Jesús Prìeto, Antonio Fontanellas	50
20	Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury. 2009 ·PubMed ·Carmen Berasain, Ana Sampedro, Itsaso Mauleón, Saioa Goñi, María U. Latasa, (unknown), María García‐Bravo, Carmen Unzu, Fernando J. Corrales, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Matías A. Ávila, Antonio Fontanellas	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact